Investor Presentaiton

(5.0%) 0.0% Dec 2014 5.0% Mar 2015 Jun 2015 Sep 2015 10.0% 15.0% Dec 2015 Mar 2016 20.0% 12 month rolling growth rate by services Long Term Average 2.9% DI INDUSTRY COVID-19 IMPACT: AUSTRALIA Industry growth rates, on a 12-month rolling basis, came back strongly in CY21, however declined significantly in CY22 given the onset of the Omicron variant of COVID-19, together with influenza, together with the lingering impact of these events In Australia, IDX recorded solid gains in market share, evidenced by a 4.1% revenue increase in its organic business (Q1 2.0%; Q2 6.2%; January 2023 double digit growth) in comparison to Medicare Benefits for the States in which IDX operates which have seen a 1.2% decrease in weighted average benefits paid for 1H FY23 adjusted for working days Industry growth Jun 2016 Sep 2016 Dec 2016 --Long Term Average 5.8% 12 month rolling growth rate by benefits Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Source: Medicare Australia Statistics by 'Broad Type of Service' (BTOS), for the States in which IDX operates. Published industry data is not available for the New Zealand market. Kidx

View entire presentation